Plain-English translation of NCT06093100 on ClinicalTrials.gov ↗ · Source last updated · Translation generated ·
This research study uses wearable technology—similar to fitness trackers—to monitor blood sugar levels and heart rate patterns in people with Duchenne muscular dystrophy (DMD). Researchers want to understand how DMD affects the body's ability to manage blood sugar, since people with DMD often take steroids and have reduced muscle activity, both of which can increase diabetes risk. By collecting this information, the study aims to create better screening guidelines and lay the groundwork for future treatments.
People with Duchenne muscular dystrophy face multiple risk factors for developing high blood sugar and insulin resistance—including long-term steroid use, reduced physical activity, and muscle loss—but very little research has actually measured how common these problems are in this population. This study is designed to fill that gap and help doctors better understand and prevent diabetes in DMD.
You likely qualify if…
You likely don't qualify if…
You would visit the research clinic at Vanderbilt once after fasting overnight. During this visit, you would have a physical exam, a blood sugar test, blood drawn for lab work, a bone density scan, and a heart imaging scan. You would then wear three small monitoring devices at home for about 1–2 weeks: a continuous glucose monitor (like a small patch that tracks blood sugar), an activity monitor (similar to a fitness tracker), and possibly a heart rate monitor. The study is expected to last about 6 years overall as researchers follow about 10 participants.
AI-generated summary from trial data · Jun 25, 2026 · Not medical advice
United States